Interleukin-17 and interleukin-23 cytokine profiles in palindromic rheumatism: potential therapeutic targets and prognostic biomarkers for disease progression to rheumatoid arthritis
Molecular Biology Reports · 2025
DOI: 10.1007/s11033-025-10786-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2025. Verfasst von Kamran Javidi-Aghdam und 7 weiteren Autor:innen. Beteiligte Einrichtung: Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Interleukin-17, Interleukin-23. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Tabriz University of Medical Sciences.
Abstract (Originalsprache)
BACKGROUND: Palindromic rheumatism (PR) is a rare autoimmune disorder characterized by recurrent inflammatory episodes, often progressing to more severe forms of arthritis, such as rheumatoid arthritis (RA). The interleukin (IL)-17/23 axis plays a crucial role in autoimmunity and joint inflammation; however, its involvement in PR remains unclear. This study aimed to investigate mRNA expression and serum levels of IL-17 and IL-23 in PR, RA, and healthy controls (HCs). METHODS: This cross-sectional study included 20 PR patients, 40 RA patients, and 40 age- and gender-matched HCs. Serum cytokine levels and gene expression were assessed using enzyme-linked immunosorbent assay (ELISA) and real-time polymerase chain reaction (qPCR). Correlations between cytokine levels, joint involvement, and disease activity were analyzed. RESULTS: Serum and mRNA expression levels of IL-17 and IL-23 were significantly higher in PR and RA patients compared to HCs. Notably, IL-17 and IL-23 levels were significantly higher in PR patients than RA patients, suggesting distinct inflammatory mechanisms. There was a significant positive correlation between IL-17 and IL-23 expression levels in PR and RA groups. However, no significant association was found between cytokine levels with clinical manifestations, autoantibodies and disease activity in PR and RA groups. CONCLUSION: The research findings provide valuable insights into immune imbalances and increased gene expression and protein levels of IL-17 and IL-23 in PR patients, offering potential therapeutic targets. Targeting these cytokines or their receptors may provide novel therapeutic strategies to prevent PR progression to RA. CLINICAL TRIAL NUMBER: Not applicable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Tuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, P.O. Box: 5165665811, Tabriz, Iran. azamsafary@yahoo.com.
- Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. dr_khabbazi@yahoo.com.
Förderung
- Tabriz University of Medical Sciences
Zitieren
APA
Javidi-Aghdam, K., Akbarzadeh-Khiavi, M., Ghasembaglou, A., Rahbari, B., Mahdavi, A. M., Jafarpour, M., Safary, A., & Khabbazi, A. (2025). Interleukin-17 and interleukin-23 cytokine profiles in palindromic rheumatism: potential therapeutic targets and prognostic biomarkers for disease progression to rheumatoid arthritis. Molecular Biology Reports. https://doi.org/10.1007/s11033-025-10786-8
Vancouver
Javidi-Aghdam K, Akbarzadeh-Khiavi M, Ghasembaglou A, Rahbari B, Mahdavi AM, Jafarpour M, et al. Interleukin-17 and interleukin-23 cytokine profiles in palindromic rheumatism: potential therapeutic targets and prognostic biomarkers for disease progression to rheumatoid arthritis. Molecular Biology Reports. 2025. doi:10.1007/s11033-025-10786-8
BibTeX
@article{JavidiAghdam2025,
author = {Javidi-Aghdam, Kamran and Akbarzadeh-Khiavi, Mostafa and Ghasembaglou, Arezoo and Rahbari, Bita and Mahdavi, Aida Malek and Jafarpour, Mehdi and Safary, Azam and Khabbazi, Alireza},
title = {Interleukin-17 and interleukin-23 cytokine profiles in palindromic rheumatism: potential therapeutic targets and prognostic biomarkers for disease progression to rheumatoid arthritis},
journal = {Molecular Biology Reports},
year = {2025},
doi = {10.1007/s11033-025-10786-8}
}
EUVIMED